OCRA News
Anne van Harten, PhD | Meet a Scientist
Dr. Anne van Harten, of the Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia, is a 2021 recipient of OCRA’s Ann and Sol Schreiber Mentored Investigator Award…
OCRA-Funded Research Reveals How Distinct Mutational Processes May Affect HGSOC Tumor Growth
OCRA grantees Ignacio Vázquez-García, PhD and Sohrab Shah, PhD, of Memorial Sloan Kettering Cancer Center, along with colleagues, have found that distinct mutational processes determine the different mechanisms by which certain…
Sammy Ferri-Borgogno, PhD | Meet a Scientist
Dr. Sammy Ferri-Borgogno, of UT MD Anderson Cancer Center, is a 2021 recipient of OCRA’s Ann and Sol Schreiber Mentored Investigator Award…
Arun Kanakkanthara, PhD | Meet a Scientist
Dr. Arun Kanakkanthara, of Mayo Clinic, is a 2021 recipient of OCRA’s Liz Tilberis Early Career Award. With his project, “Exploiting a Metabolic Dependency of PARPinhibitor-Resistant Ovarian Cancer,” Dr…
Wei Zhou, PhD | Meet a Scientist
Dr. Wei Zhou, of The Wistar Institute in Philadelphia, is a 2021 recipient of OCRA’s Ann & Sol Schreiber Mentored Investigator Award, mentored by Dr. Rugang Zhang…
The Overview: December 2021
This time of year always has us reflecting on what we’ve accomplished, what we hope to achieve in the future, and how we — with the support of the entire ovarian cancer community — can lean in even harder to our commitment…
Announcing The Edmée Firth Fund for Research in Ovarian Cancer
Ovarian Cancer Research Alliance (OCRA) is proud to announce the establishment of a major new research partnership with Nicholas Firth and the Jean & Louis Dreyfus Foundation to be known as The Edmée Firth Fund for Research in Ovarian…
OCRA-Funded Research Identifies New “Master” Drug Targets for Ovarian Cancer
An interdisciplinary group of researchers from around the country analyzed tumor samples from nearly 10,000 patients with 34 types of cancer to reveal unique genetic switches associated with each tumor type…
Apply Today for OCRA’s 2022 Advocate Leader Program
The application period has now closed. Apply today to join survivors, caregivers and activists across the country to affect change for those impacted by ovarian cancer…
Liya Ding, PhD | Meet a Scientist
Dr. Liya Ding, of Dana-Farber Cancer Institute, is a 2021 recipient of OCRA’s Liz Tilberis Early Career Award. With her project, “Targeting Therapeutic Resistance to PARP Inhibition in Ovarian Cancer,” Dr…
How to Cope With Cancer
A cancer diagnosis of any type can stress both body and mind, but ovarian cancer takes a particularly high psychological toll on those living with the disease, according to recent research…
FDA Approves Drug to Identify Ovarian Cancer Lesions During Surgery
In what could prove to be a game-changer for ovarian cancer debulking procedures, the U.S…